Buspirone analogs. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives
- 1 February 1983
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 26 (2) , 194-203
- https://doi.org/10.1021/jm00356a014
Abstract
A series of analogs of buspirone was synthesized in which modifications were made in the aryl moiety, alkylene chain length and cyclic imide portion of the molecule. These compounds were tested in vitro for their binding affinities to rat brain membrane sites labeled by either the dopamine antagonist [3H]spiperone or the .alpha.1-adrenergic antagonist [3H]WB-4101 [2-[N-(2,6-dimethoxyphenoxyethyl)]aminomethyl-1,4-benzodioxane]. Compounds were tested in vivo for tranquilizing properties and induction of catalepsy. Potency at the [3H]spiperone binding site was affected by alkylene chain length and imide portion composition. Non-ortho substituents on the aryl moiety had effect on [3H]spiperone binding affinity. Structure-activity relationships of ortho substituents demonstrated only modest correlations between the receptor binding data and physical parameters of the substituents. The complex nature of the drug-receptor interactions may be understood in terms of the fit of buspirone to a hypothetical model of the dopamine receptor.This publication has 6 references indexed in Scilit:
- Dopamine receptor model and its application in the design of a new class of rigid pyrrolo[2,3-g]isoquinoline antipsychoticsJournal of Medicinal Chemistry, 1981
- The comparative efficacy of buspirone and diazepam in the treatment of anxietyAmerican Journal of Psychiatry, 1979
- Mapping the dopamine receptor. 1. Features derived from modifications in ring E of the neuroleptic butaclamolJournal of Medicinal Chemistry, 1979
- Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamolJournal of Medicinal Chemistry, 1979
- Effects on striatal and mesolimbic dopamine systems of a new potential antipsychotic drug -mezilamine- with weak cataleptogenic propertiesLife Sciences, 1978
- PROPERTIES OF [HALOPERIDOL-H-3] AND [DOPAMINE-H-3] BINDING ASSOCIATED WITH DOPAMINE RECEPTORS IN CALF BRAIN MEMBRANES1976